The STRIDE Trial is the largest pragmatic, cluster randomized, parallel group superiority trial with practices stratified by healthcare system and patients nested within practices. Fall injuries are a major public health problem. Thirty percent of people over the age of 65 fall each year, and for those over 75 the rates are even higher. Serious fall injuries, including fractures and other falls leading to medical attention, are a common source of disability and death among the elderly. This randomized trial will determine the effectiveness of an evidence-based, multifactorial, patient-centered intervention to reduce the risk of serious fall injuries among non-institutionalized older persons. The original target sample size was 6,000 participants enrolled from 86 practices to provide 90% power to detect a 20% reduction in the rate of the primary outcome with intervention relative to control. Later, the duration of the trial was extended to a total of 40 months (20 months of recruitment and an additional 20 months of follow-up), which reduced the target sample size to 5,322 participants. Recruitment ended after 20 months on March 31, 2017, with a total of 5,451 participants enrolled. The intervention phase ended on November 30, 2018 and follow-up will end on March 31, 2019. The primary aim of this administrative supplemental application is to request funds to carry out trial close-out activities of the STRIDE Trial necessitated by the extension of the intervention and the follow-up period as a result of the two DSMB-approved modifications in the trial's design. In December 2017, the trial's DSMB and the NIA approved the extension of the duration of the study from 36 months (18 months of recruitment and a minimum 18 months of follow-up) to 40 months (20 months of recruitment and a minimum of 20 months of follow-up). Based on an analysis of the event rate of the primary outcome in a closed session, the trial's DSMB and the NIA staff directed the study team to Extend the study from a minimum of 20 and maximum of 40 months follow-up to a minimum of 24 and maximum of 44 months of follow-up. Final end date of the study, including the analytic phase is now extended to April 30, 2020. Because of the extension of the intervention duration and the follow-up period, the project's end date was extended to April 30, 2020. The close-out funds are necessary for completing the data collection, adjudication of the primary outcome, analyses of the primary and secondary outcomes as described in the peer-reviewed and funded grant application, preparation of the study reports and manuscripts, and orderly close-out of the trial. The supplement does not change the specific aims or scope of the parent grant application and is required for trial's close-out activities resulting from implementation of the DSMB and NIA-approved extension of the intervention and follow-up period.

Public Health Relevance

The STRIDE Trial, one of the largest pragmatic, cluster randomized, parallel group superiority trial of an individually-tailored multifactorial fall-injury prevention strategy administered by a Falls Care Manager in the setting of primary care practices. The DSMB-approved extension of the duration of the follow-up to a minimum of 24 months and a maximum of 44 months has extended the project's end date to April 30, 2020. The primary aim of this administrative supplemental application is to request funds to carry out the close-out activities of the STRIDE Trial necessitated by the extension of the intervention and the follow-up period as a result of the two DSMB-approved modifications in the trial's design.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01AG048270-05S1
Application #
9883937
Study Section
Program Officer
Romashkan, Sergei
Project Start
2014-05-03
Project End
2020-11-30
Budget Start
2019-08-15
Budget End
2020-11-30
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115